---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-051517"
form_type: "8-K"
ticker: "MRK"
cik: "0000310158"
company_name: "Merck & Co., Inc."
filed_at: "2024-04-25T23:59:59+00:00"
generated_at: "2026-06-03T08:25:24.890282+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Merck Q1 sales up 9% to $15.8B; raises FY2024 sales and EPS guidance

## Summary
- GAAP EPS $1.87 (+68% YoY); Non-GAAP EPS $2.07 (+48% YoY). Sales $15.775B (+9%, +12% ex-FX).
- Keytruda sales grew 20% to $6.9B; Gardasil sales up 14% to $2.2B on strong China demand.
- Full-year 2024 sales outlook raised to $63.1-$64.3B; Non-GAAP EPS outlook raised to $8.53-$8.65.
- Received FDA approval for WINREVAIR (PAH); closed Harpoon acquisition with $656M charge.
- Proposed acquisition of Elanco's aqua business to broaden animal health portfolio.

## SEC filing metadata
- accession: 0001104659-24-051517
- form_type: 8-K
- ticker: MRK
- cik: 0000310158
- company_name: Merck & Co., Inc.
- filed_at: 2024-04-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310158/000110465924051517/0001104659-24-051517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310158/000110465924051517/tm2412490d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-051517
- JSON: https://secwatch.observer/filing/0001104659-24-051517.json
- Plain text: https://secwatch.observer/filing/0001104659-24-051517.txt

## Key facts
- Earnings Releases
  Merck & Co., Inc. reported first quarter of 2024 results: revenue $15,775, net income 4,762, EPS GAAP EPS 1.87; Non-GAAP EPS that excludes certain items 2* 2.07. Guidance raised.
  - Period: first quarter of 2024
  - Revenue: $15,775
  - Net income: 4,762
  - EPS: GAAP EPS 1.87; Non-GAAP EPS that excludes certain items 2* 2.07
  - Guidance: raised
  - Result: reported results
  source text: Financial Summary First Quarter $ in millions, except EPS amounts 2024 2023 Change Change Ex- Exchange Sales $ 15,775 $ 14,487 9 % 12 % GAAP net income 1 4,762 2,821 69 % 76 % Non-GAAP net income that excludes certain items 1,2* 5,279 3,564 48 % 54 % GAAP EPS 1.87 1.11 68 % 76 % Non-GAAP EPS that excludes certain items 2* 2.07 1.40 48 % 54 %
  evidence_url: https://www.sec.gov/Archives/edgar/data/310158/000110465924051517/0001104659-24-051517-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.